Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Nov 27;13(12):4289.
doi: 10.3390/nu13124289.

Changes in Circulating Metabolites during Weight Loss and Weight Loss Maintenance in Relation to Cardiometabolic Risk

Affiliations
Randomized Controlled Trial

Changes in Circulating Metabolites during Weight Loss and Weight Loss Maintenance in Relation to Cardiometabolic Risk

Christopher Papandreou et al. Nutrients. .

Abstract

(1) Background: There is a substantial lack of knowledge of the biochemical mechanisms by which weight loss and weight regain exert their beneficial and adverse effects, respectively, on cardiometabolic outcomes. We examined associations between changes in circulating metabolites and changes in cardiometabolic risk factors during diet-induced weight loss and weight loss maintenance. (2) Methods: This prospective analysis of data from the Satiety Innovation (SATIN) study involved adults living with overweight and obesity (mean age=47.5). One hundred sixty-two subjects achieving ≥8% weight loss during an initial 8-week low-calorie diet (LCD) were included in a 12-week weight loss maintenance period. Circulating metabolites (m=123) were profiled using a targeted multiplatform approach. Data were analyzed using multivariate linear regression models. (3) Results: Decreases in the concentrations of several phosphatidylcholines (PCs), sphingomyelins (SMs), and valine were consistently associated with decreases in total (TChol) and low-density lipoprotein cholesterol (LDL-C) levels during the LCD. Increases in PCs and SMs were significantly associated with increases in TChol and LDL-C during the weight loss maintenance period. Decreases and increases in PCs during LCD and maintenance period, respectively, were associated with decreases in the levels of triglycerides. (4) Conclusions: The results of this study suggest that decreases in circulating PCs and SMs during weight loss and the subsequent weight loss maintenance period may decrease the cardiovascular risk through impacting TChol and LDL-C.

Keywords: SATIN; cardiometabolic risk; metabolomics; weight loss; weight maintenance.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest of the study.

Figures

Figure 1
Figure 1
Metabolite set enrichment analysis. (A) Over representation analysis was implemented in the enrichment analysis of MetaboAnalyst 5.0 using the hypergeometric test to evaluate whether a particular metabolite set is represented more than expected by chance within the metabolites previously selected for TChol and LDL-C. One-tailed p values are provided after false discovery rate-adjusting for multiple testing. Abbreviations: SM, sphingomyelin. (B) Over-representation analysis was implemented in the enrichment analysis of MetaboAnalyst 5.0 using the hypergeometric test to evaluate whether a particular metabolite set is represented more than expected by chance within the metabolites previously selected for triglyceride. One-tailed p values are provided after false discovery rate-adjusting for multiple testing.

References

    1. Aslibekyan S., Garvey W.T. Obesity: Obesity and cardiometabolic disease—More than meets the eye. Nat. Rev. Endocrinol. 2017;13:566–568. doi: 10.1038/nrendo.2017.112. - DOI - PubMed
    1. Poirier P., Giles T.D., Bray G.A., Hong Y., Stern J.S., Pi-Sunyer F.X., Eckel R.H. American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113:898–918. - PubMed
    1. Franz M.J., VanWormer J.J., Crain A.L., Boucher J.L., Histon T., Caplan W., Bowman J.D., Pronk N.P. Weight-loss outcomes: A systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J. Am. Diet. Assoc. 2007;107:1755–1767. doi: 10.1016/j.jada.2007.07.017. - DOI - PubMed
    1. Lagerros Y.T., Rössner S. Obesity management: What brings success? Ther. Adv. Gastroenterol. 2013;6:77–88. doi: 10.1177/1756283X12459413. - DOI - PMC - PubMed
    1. Magkos F., Fraterrigo G., Yoshino J., Luecking C., Kirbach K., Kelly S.C., De Las Fuentes L., He S., Okunade A.L., Patterson B.W., et al. Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity. Cell Metab. 2016;23:591–601. doi: 10.1016/j.cmet.2016.02.005. - DOI - PMC - PubMed

Publication types

MeSH terms